PROKID
Follow-up using Patient-Reported Outcome (PRO) measures in patients with chronic kidney disease:The PROKID study - A randomised controlled trial.
Outpatient care is steadily changing from hospital consultations to other platforms. It is prudent to maintain quality of care with such initiatives. Currently, patients with chronic kidney disease (CKD) have frequent scheduled visits, but it may be possible to optimise the frequency of hospital consultations using information from patient-reported outcome (PRO) questionnaires filled in at home (PRO-based follow-up). We aimed to evaluate the effectiveness of the quality of care, use of resources and patient outcomes associated with PRO-based follow-up in patients with CKD.
Newly referred patients with an estimated glomerular filtration rate (eGFR) of ≤ 40 ml/min 1.73m2 will be randomised to either:1. PRO-based remote follow-up; 2. PRO-based telephone consultation; 3. Usual outpatient follow-up (control group). A disease-specific PRO questionnaire will in part be used as a screening tool to identify patients in need of outpatient contact and to identify symptom burden. Responses from the questionnaire will be processed according to a disease-specific algorithm and assigned green, yellow or red status according to patients’ needs. If PRO-based follow-up proves non-inferior to usual outpatient follow-up, a reorganisation of routine clinical practice in nephrology outpatient clinics may occur.
Researchers: